Antineutrophil cytoplasmic antibody mediated glomerulonephritis associated with levamisole-adulterated cocaine

Levamisole-adulterated cocaine has increased in prevalence over the last decade and is known to be associated with antineutrophil cytoplasmic antibodies (ANCA). Dermatologic manifestations of levamisole exposure, including cutaneous vasculitis, are widely appreciated; less is known about its effects on the kidney. We report two cases of patients with a history of cocaine abuse and levamisole-induced cutaneous vasculitis, who developed acute kidney injury in the setting of elevated ANCA titers. Renal biopsies of both revealed pauci-immune complex glomerulonephritis with diffuse crescentic disease. These cases demonstrate a rare but serious complication of long-term cocaine use.

[1]  C. Streutker,et al.  Plasmapheresis and Steroid Treatment of Levamisole-Induced Vasculopathy and Associated Skin Necrosis in Crack/Cocaine Users , 2013, Journal of cutaneous medicine and surgery.

[2]  P. Meroni,et al.  Cocaine-induced midline destructive lesions - an autoimmune disease? , 2013, Autoimmunity reviews.

[3]  D. Patterson,et al.  Levamisole-Adulterated Cocaine: A Case Series , 2012, The Journal of the American Board of Family Medicine.

[4]  W. High,et al.  Levamisole-induced Wegener's granulomatosis following contaminated cocaine abuse. , 2012, SKINmed Dermatology for the Clinician.

[5]  M. Driscoll,et al.  Vasculopathy related to cocaine adulterated with levamisole: A review of the literature. , 2012, Dermatology online journal.

[6]  D. Federman,et al.  Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. , 2012, Mayo Clinic proceedings.

[7]  H. Rennke,et al.  Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[8]  S. Lata,et al.  Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. , 2011, Seminars in arthritis and rheumatism.

[9]  Samuel H. Poon,et al.  Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia. , 2011, Seminars in arthritis and rheumatism.

[10]  J. Graf,et al.  Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. , 2011, Arthritis and rheumatism.

[11]  K. Heard,et al.  Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. , 2011, JAMA.

[12]  A. Wollenberg,et al.  PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. , 2008, Acta dermato-venereologica.

[13]  M. Iqbal,et al.  Immunomodulatory effect of various anti-parasitics: a review , 2005, Parasitology.

[14]  G. Blair,et al.  The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant , 1995, Cancer Immunology and Immunotherapy.

[15]  Augustine S. Lee,et al.  Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. , 2004, Arthritis and rheumatism.

[16]  P. Cockwell,et al.  Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. , 2001, Kidney international.

[17]  G. Ghiggeri,et al.  Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome , 1999, Pediatric Nephrology.

[18]  A. Edefonti,et al.  Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long‐term treatment with levamisole in children , 1999, The British journal of dermatology.

[19]  A. Edefonti,et al.  Ear Lobe Bilateral Necrosis by Levamisole‐Induced Occlusive Vasculitis in a Pediatric Patient , 1997, Pediatric dermatology.

[20]  M. Bianchetti,et al.  Vasculitis associated with levamisole and circulating autoantibodies. , 1996, Archives of disease in childhood.

[21]  G. Caillé,et al.  Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. , 1986, Biopharmaceutics & drug disposition.

[22]  M. Scheinberg,et al.  Cutaneous necrotising vasculitis induced by levamisole. , 1978, British medical journal.

[23]  P. Bacon,et al.  Levamisole-induced vasculitis due to circulating immune complexes. , 1978, British medical journal.

[24]  G. Renoux,et al.  Potentiation of T-cell mediated immunity by levamisole. , 1976, Clinical and experimental immunology.